Concordance of PD-L1 combined positive score (CPS) analysis between primary gastric cancer and matched peritoneal metastasis.
Concordance
DOI:
10.1200/jco.2024.42.16_suppl.e16068
Publication Date:
2024-07-02T01:30:41Z
AUTHORS (18)
ABSTRACT
e16068 Background: Peritoneum represents one of the most common metastatic sites gastroesophageal adenocarcinoma (GEA) and is associated with poor prognosis. Programmed death-ligand 1 (PD-L1) expression a recognized predictive biomarker response to immune checkpoint inhibitors (ICIs) in first-line setting. However, data from pivotal trials showed poorer clinical efficacy ICIs sub-set patients peritoneal involvement, regardless PD-L1 score magnitude. Here, we investigated temporal spatial heterogeneity between primary tumor matched metastasis. Methods: according CPS was determined by immunohistochemistry using VENTANA (SP263) assays on formalin-fixed paraffin-embedded (FFPE) tissues derived 22 treated at our institution for advanced GEA September 2015 August 2023. Concordance rate metastasis cut-off 5 reported (spatial heterogeneity); additionally, concordance value before after administration systemic treatments analyzed (temporal heterogeneity). Results: 12(54.5%)/5(22.7%) samples 12(54.5%)/1(4.5%) metastases ≥ 1/ 5, respectively. specimens 54.5% 72.7% cuts-off respectively, highlighting marked heterogeneity. High (94%) negative metastases, against 5; contrast, none positive retained peritoneum. Evident also observed, 56% pre- versus post-treatment comparison. Conclusions: characterized which more prominent lower cut-offs values. This evidence could hamper its role as ICIs. The high intra-patient discordance suggests that should not be recommended preferred source assessment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....